Literature DB >> 3632352

Comparison of benzo(a)pyrene metabolism in isolated perfused rat lung and liver.

M Mollière, H Foth, R Kahl, G F Kahl.   

Abstract

The metabolism of 1 mM benzo(a)pyrene was studied in isolated perfused lung and liver of 5,6-benzoflavone-pretreated rats. Benzo(a)pyrene metabolism by the liver was more rapid than by the lung, but total metabolite formation in the lung at the end of a 120-min perfusion period was comparable to that in the liver. Lung perfusate was characterized by high concentrations of free metabolites, with diols outweighing phenols; in liver perfusate free metabolite concentrations were low, and large quantities of metabolites were found as conjugates in the bile at the end of perfusion. The tissue concentrations of free diols and phenols including the precursors of the main DNA-binding secondary metabolites were higher in the lung than in the liver. These findings explain the similar level of covalent binding in perfused lung and liver previously described (Klaus et al. 1982).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3632352     DOI: 10.1007/BF01234665

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  36 in total

1.  Biochemical studies of toxic agents. 11. The occurrence of premercapturic acids.

Authors:  R H KNIGHT; L YOUNG
Journal:  Biochem J       Date:  1958-09       Impact factor: 3.857

2.  Glucuronide synthesis in the rat and guinea pig lung.

Authors:  A Aitio
Journal:  Xenobiotica       Date:  1973-01       Impact factor: 1.908

3.  The role of microsomal drug-metabolizing enzymes in the biliary excretion of 3,4-benzpyrene in the rat.

Authors:  W G Levine
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

4.  Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration.

Authors:  H Foth; M Mollière; R Kahl; E Jähnchen; G F Kahl
Journal:  Drug Metab Dispos       Date:  1984 Nov-Dec       Impact factor: 3.922

5.  Metabolism and DNA binding of benzo(a)pyrene in vivo in the rat.

Authors:  M Boroujerdi; H Kung; A G Wilson; M W Anderson
Journal:  Cancer Res       Date:  1981-03       Impact factor: 12.701

6.  Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.

Authors:  J Kapitulnik; P G Wislocki; W Levin; H Yagi; D M Jerina; A H Conney
Journal:  Cancer Res       Date:  1978-02       Impact factor: 12.701

7.  Metabolism and covalent binding of benzo[alpha]pyrene in human peripheral lung.

Authors:  R Mehta; M Meredith-Brown; G M Cohen
Journal:  Chem Biol Interact       Date:  1979-12       Impact factor: 5.192

8.  Binding of benzo(a)pyrene metabolites to cellular DNA in perfused rat lungs.

Authors:  B Deckers-Schmelzle; E Klaus; R Kahl; G F Kahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

9.  Gluconeogenesis in the perfused rat liver.

Authors:  R Hems; B D Ross; M N Berry; H A Krebs
Journal:  Biochem J       Date:  1966-11       Impact factor: 3.857

10.  Clearance of benzo(a)pyrene by isolated rat liver and lung: alterations in perfusion and metabolic capacity.

Authors:  D A Wiersma; R A Roth
Journal:  J Pharmacol Exp Ther       Date:  1983-04       Impact factor: 4.030

View more
  2 in total

1.  Benzo(a)pyrene-albumin adducts in humans exposed to polycyclic aromatic hydrocarbons in an industrial area of Poland.

Authors:  E H Kure; A Andreassen; S Ovrebø; E Grzybowska; Z Fiala; M Strózyk; M Chorazy; A Haugen
Journal:  Occup Environ Med       Date:  1997-09       Impact factor: 4.402

2.  Understanding the linked kinetics of benzo(a)pyrene and 3-hydroxybenzo(a)pyrene biomarker of exposure using physiologically-based pharmacokinetic modelling in rats.

Authors:  Roberto Heredia-Ortiz; Michèle Bouchard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-10-29       Impact factor: 2.745

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.